Manso L, Moreno F, Márquez R, Castelo B, Arcediano A, Arroyo M, Ballesteros AI, Calvo I, Echarri MJ, Enrech S, Gómez A, González Del Val R, López-Miranda E, Martín-Angulo M, Martínez-Jañez N, Olier C, Zamora P.

Use of bevacizumab as a first-line treatment for metastatic breast cancer

Current Oncology 2015. 22(2): 51-60. Nº de citas: 14

[doi:10.3747/co.22.2210]

Morales P, Blasco-Benito S, Andradas C, Gómez-Cañas M, Flores JM, Goya P, Fernández-Ruiz J, Sánchez C, Jagerovic N.

Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against Triple-Negative Breast Cancer

JOURNAL OF MEDICINAL CHEMISTRY 2015. 58(5): 2256-2264. Nº de citas: 26

[doi:10.1021/acs.jmedchem.5b00078]

García MC, Cinquina V, Palomo-Garo C, Rábano A, Fernández-Ruiz J.

Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson's disease

NEUROSCIENCE LETTERS 2015. 587: 1-4. Nº de citas: 61

[doi:10.1016/j.neulet.2014.12.003]

Fernández-Ruiz J, Romero J, Ramos JA.

Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.

Handbook of experimental pharmacology 2015. 231: 233-259.

[doi:10.1007/978-3-319-20825-1_8]

Valdeolivas S, Navarrete C, Cantarero I, Bellido ML, Muñoz E, Sagredo O.

Neuroprotective Properties of Cannabigerol in Huntington's Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice

Neurotherapeutics 2015. 12(1): 185-199. Nº de citas: 67

[doi:10.1007/s13311-014-0304-z]

Ooms M, Rietjens R, Rangarajan JR, Vunckx K, Valdeolivas S, Maes F, Himmelreich U, Fernandez-Ruiz J, Bormans G, Van Laere K, Casteels C.

Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice

NEUROBIOLOGY OF AGING 2014. 35(12): 2858-2869. Nº de citas: 24

[doi:10.1016/j.neurobiolaging.2014.06.010]

Fernandes VS, Ribeiro AS, Martínez P, López-Oliva ME, Barahona MV, Orensanz LM, Martínez-Sáenz A, Recio P, Benedito S, Bustamante S, García-Sacristán A, Prieto D, Hernández M.

Hydrogen Sulfide Plays a Key Role in the Inhibitory Neurotransmission to the Pig Intravesical Ureter

Plos One 2014. 9(11): . Nº de citas: 19

[doi:10.1371/journal.pone.0113580]

Calatrava-Ferreras L, Gonzalo-Gobernado R, Reimers D, Herranz AS, Jiménez-Escrig A, Díaz-Gil JJ, Casarejos MJ, Montero-Vega MT, Bazán E.

Neuroprotective Role of Liver Growth Factor ``LGF'' in an Experimental Model of Cerebellar Ataxia

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2014. 15(10): 19056-19073. Nº de citas: 4

[doi:10.3390/ijms151019056]

Casarejos MJ, Perucho J, López-Sendón JL, García de Yébenes J, Bettencourt C, Gómez A, Ruiz C, Heutink P, Rizzu P, Mena MA.

Trehalose Improves Human Fibroblast Deficits in a New CHIP-Mutation Related Ataxia

Plos One 2014. 9(9): . Nº de citas: 21

[doi:10.1371/journal.pone.0106931]

Moreno-Martet M, Espejo-Porras F, Fernández-Ruiz J, de Lago E.

Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1(G93A) Transgenic Mice and Evaluation of a Sativex (R)-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis

CNS NEUROSCIENCE & THERAPEUTICS 2014. 20(9): 809-815. Nº de citas: 37

[doi:10.1111/cns.12262]

Moreno E, Andradas C, Medrano M, Caffarel MM, Pérez-Gómez E, Blasco-Benito S, Gómez-Cañas M, Pazos MR, Irving AJ, Lluís C, Canela EI, Fernández-Ruiz J, Guzmán M, McCormick PJ, Sánchez C.

Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling

JOURNAL OF BIOLOGICAL CHEMISTRY 2014. 289(32): 21960-21972. Nº de citas: 71

[doi:10.1074/jbc.M114.561761]

Chiarlone A, Bellocchio L, Blázquez C, Resel E, Soria-Gómez E, Cannich A, Ferrero JJ, Sagredo O, Benito C, Romero J, Sánchez-Prieto J, Lutz B, Fernández-Ruiz J, Galve-Roperh I, Guzmán M.

A restricted population of CB1 cannabinoid receptors with neuroprotective activity

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2014. 111(22): 8257-8262. Nº de citas: 109

[doi:10.1073/pnas.1400988111]

Ribeiro AS, Fernandes VS, Martínez MP, Martínez-Sáenz A, Pazos MR, Orensanz LM, Recio P, Bustamante S, Carballido J, García-Sacristán A, Prieto D, Hernández M.

Neuronal and non-neuronal bradykinin receptors are involved in the contraction and/or relaxation to the pig bladder neck smooth muscle

NEUROUROLOGY AND URODYNAMICS 2014. 33(5): 558-565. Nº de citas: 3

[doi:10.1002/nau.22434]

Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D.

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

Epilepsia 2014. 55(6): 791-802. Nº de citas: 502

[doi:10.1111/epi.12631]

Rodríguez-Cueto C, Benito C, Fernández-Ruiz J, Romero J, Hernández-Gálvez M, Gómez-Ruiz M.

Changes in CB1 and CB2 receptors in the post- mortem cerebellum of humans affected by spinocerebellar ataxias

BRITISH JOURNAL OF PHARMACOLOGY 2014. 171(6, SI): 1472-1489. Nº de citas: 39

[doi:10.1111/bph.12283]

Fernandez-Estevez MA, Casarejos MJ, López Sendon J, Garcia Caldentey J, Ruiz C, Gomez A, Perucho J, de Yebenes JG, Mena MA.

Trehalose Reverses Cell Malfunction in Fibroblasts from Normal and Huntington's Disease Patients Caused by Proteosome Inhibition

Plos One 2014. 9(2): . Nº de citas: 43

[doi:10.1371/journal.pone.0090202]

González-Naranjo P, Pérez-Macias N, Campillo NE, Pérez C, Arán VJ, Girón R, Sánchez-Robles E, Martín MI, Gómez-Cañas M, García-Arencibia M, Fernández-Ruiz J, Páez JA.

Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2014. 73: 56-72. Nº de citas: 36

[doi:10.1016/j.ejmech.2013.11.026]

Gonzalo-Gobernado R, Calatrava-Ferreras L, Perucho J, Reimers D, Casarejos MJ, Herranz AS, Jimenez-Escrig A, Diaz-Gil JJ, Bazan E.

Liver growth factor as a tissue regenerating factor in neurodegenerative diseases.

Recent patents on CNS drug discovery 2014. 9(3): 173-180.